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conditions agree with patients that the relief was
well worth the effort. However, longer therapy, ad-
ditional approaches, or both are required to pro-
duce a more lasting cure.
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Mutation of Perinatal Myosin Heavy Chain
 
to the editor: 
 
Veugelers et al. (July 29 issue)
 
1
 
 re-
port on patients with the trismus–pseudocampto-
dactyly syndrome as having a “Carney complex
variant.” Among more than 500 patients with the
Carney complex in our database, there are none with
the trismus–pseudocamptodactyly syndrome.
 
2,3
 
In our analysis of patients reported to have the
trismus–pseudocamptodactyly syndrome, we iden-
tified several with freckling. These patients ap-
peared to have a familial disorder at variance with
the Carney complex — not a simple Carney com-
plex variant. The dictionary definition of variant is
“varying usually slightly from the standard form.”
By contrast, patients with the trismus–pseudo-
camptodactyly syndrome have none of the lesions
or endocrine syndromes that are typical of the Car-
ney complex.
 
2
 
 The confusion caused by the suggest-
ed terminology is apparent in the Perspective arti-
cle that accompanies the report by Veugelers et al.:
in that article, the table listing the disorders caused
by abnormal myosins refers to “Carney complex
(trismus–pseudocamptodactyly),” without the qual-
ifier “variant.”
 
4
 
 The trismus–pseudocamptodacty-
ly syndrome with freckling may or may not be asso-
ciated with familial myxomas and may or may not
be caused by a single mutation of the 
 
MYH8
 
 gene,
but our data indicate that this disorder is distinct
from the Carney complex.
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to the editor: 
 
In the report by Veugelers and col-
leagues on mutations in the 
 
MYH8
 
 gene as a cause
of the Carney complex (the trismus–pseudocamp-
todactyly syndrome), the authors report screening
the gene for variants that may be associated with iso-
lated cardiac myxoma. In 12 presumably unrelated
patients screened for the polymorphism T5147C,
4 T/T homozygotes and 8 C/C homozygotes were
identified. These findings are not in Hardy–Wein-
berg equilibrium (P<0.001), owing to the presence
of fewer than the expected number of heterozy-
gotes. Possible explanations for these findings are
that the 12 cases are actually closely related, that
there was a genotyping or typographic error, or that
a true disease association was observed, one most
likely involving one or more unidentified deletions.
Could it be that this finding does implicate 
 
MYH8
 
in “sporadic” cardiac myxoma?
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to the editor: 
 
Veugelers et al. clearly demonstrate
the novel gene mutation that is a cause of the Car-
ney complex variant. We would appreciate it if they
could provide additional data on two issues. First,
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are there any data on the morphologic or electro-
physiological abnormality of myocardium in Fam-
ily 1? A report indicating that 
 
MYH8
 
 is expressed in
the embryonic myocardium in the chick
 
1
 
 suggests
that a mutation of 
 
MYH8
 
 may impede early cardio-
genesis in humans. The influence of this genetic
defect on cardiogenesis should be studied, as well
as cardiac tumorigenesis. Such a discussion would
provide insight into the role of the perinatal myo-
sin heavy chain in cardiogenesis. Second, the poly-
morphism (M1229T) of 
 
MYH8
 
 that the authors
identify as a possible risk factor for cardiac myxo-
mas may function as a genetic modifier,
 
2
 
 which
may in part explain the difference in phenotypic ex-
pressivity between Family 1 and Families 2 and 3.
This analysis would provide a good example of
genetic modifiers within a single gene.
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the authors reply: 
 
Dr. Brown and Drs. Morita and
Nagai emphasize the potential contributions of
 
MYH8
 
 polymorphisms to cardiac myxomas. We,
too, observed the deviation from Hardy–Weinberg
equilibrium in our cohort of 12 patients with cardiac
myxomas,
 
1 
 
none of whom are apparently related.
To date, we have not found evidence of deletions to
confound the genotyping (flanking polymorphisms
show heterozygosity), but we agree that the possi-
bility of microdeletions cannot be excluded. Such
comments highlight the need for further study of
genotype–phenotype correlations in larger cohorts
and of the possible clinical effect of 
 
MYH8
 
 variants
on the risk of cardiac tumorigenesis.
Drs. Morita and Nagai also ask intriguing ques-
tions about the potential role of 
 
MYH8 i
 
n the devel-
opment of the heart. Echocardiography and elec-
trocardiography have not yet revealed congenital
malformations in Family 1, 2, or 3. However, more
detailed analyses are ongoing, and we concur with
regard to the importance of direct experimentation
to determine the contributions of 
 
MYH8
 
 to cardio-
genesis. We note that, in conformance to the policy
of the 
 
Journal,
 
 the numbering of the families de-
scribed in our report was changed from that used
in previous reports,
 
2
 
 so that correlating the clinical
findings in our report with those in the earlier re-
ports can be confusing. The ventriculogram from
family member II-7 (Family 1, or YK) in Figure 1C
of the article
 
1
 
 shows a similar image from a frame
cut from cine film of the same cardiac myxoma
shown in an earlier description of this proband.
 
2
 
Chaudron et al.
 
2
 
 showed an image of the face of
family member II-7 that bears a striking similarity
to the photograph in our report (Fig. 1B
 
1
 
) of her
daughter (III-19), who also has the Carney complex
and the trismus–pseudocamptodactyly syndrome.
Stratakis and colleagues misread our study. Al-
though the use of precise terminology is important,
we did not suggest that all patients with the trismus–
pseudocamptodactyly syndrome have a Carney com-
plex variant. Rather, we reported that some unusual
patients with typical Carney complex findings also
have the trismus–pseudocamptodactyly syndrome,
and we termed these combined disorders a Carney
complex variant. The typical Carney complex exhib-
its markedly variable expressivity,
 
3-5
 
 and the only
feature that occurs nearly uniformly is spotty pig-
mentation. Among the myriad other findings that
occasionally occur, some of the more frequent ones
are cardiac, cutaneous, and palpebral myxomas as
well as endocrine syndromes such as acromegaly.
All these cardiac, dermatologic, neoplastic, and en-
docrine manifestations were seen and reported in
the family described with the variant Carney com-
plex.
 
1,2 
 
We encourage caution when analyzing data
from previously established Carney complex data-
bases to identify persons with this rare variant.
Such a retrospective review is likely to be insensi-
tive, because the diagnosis of pseudocamptodactyly
(in contrast to camptodactyly) requires a focused
evaluation of the patient with particular physical ex-
amination maneuvers. Identification of the trismus–
pseudocamptodactyly syndrome in these cohorts
with the Carney complex requires that specifically
trained physicians reevaluate them prospectively.
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VIPoma
 
to the editor: 
 
Lubinski and Hendrix (Aug. 19 is-
sue)
 
1 provide interesting images of a VIPoma.
They report hypercalcemia (serum calcium level,
12.1 mg per deciliter [3.0 mmol per liter]) in the
patient but do not provide any information regard-
ing the cause. Rarely, hypercalcemia in this set-
ting could indicate the presence of multiple endo-
crine neoplasia type 12 and, consequently, the need
for genetic screening. Cosecretion of calcitonin by
the neuroendocrine tumor of the pancreas is an-
other possibility.3
Biswa M. Mishra, M.D.
Christie Hospital
Manchester M20 4BX, United Kingdom
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Using the Internet to Identify Infectious-Disease Outbreaks
to the editor: The Emerging Infections Network
(EIN) is a health care provider–based, sentinel net-
work that was established in 1996. Its central feature
is an e-mail list (listserv) with 946 participants from
all 50 states and 36 foreign countries. The majority
of participants are infectious-disease consultants in
academia or private practice; 16 percent work in the
public health sector. Participants communicate by
means of a closed electronic mail system and Web
site.1 The purposes of EIN are to detect new infec-
tious diseases or outbreaks, identify cases during in-
vestigations of outbreaks, acquire knowledge rapid-
ly about newer infections, facilitate research, and
foster communication and education.2 EIN has been
used successfully for the last three of these purpos-
es.3,4 However, until now there have been no re-
ports describing EIN’s usefulness in identifying or
investigating outbreaks.
On March 24, 2004, an EIN member from New
York City used the EIN listserv to request advice re-
garding the care of a patient who had a Mycobacterium
abscessus surgical-wound infection after a “tummy
tuck” performed in the Dominican Republic. This
posting was seen by a colleague in Springfield,
Massachusetts, who had recently diagnosed a sim-
ilar infection in a patient who had also undergone
abdominoplasty in the Dominican Republic. After
it was determined that the patients had undergone
surgery in the same clinic, a local investigation iden-
tified three more cases linked to that clinic. Within
24 hours of the initial contact between the two phy-
sicians, the New York City Department of Health
and the Centers for Disease Control and Prevention
(CDC) were informed of a possible outbreak. The
CDC then posted a case definition on EIN and
ProMed (another electronic listserv). As of Octo-
ber 4, 16 potential cases had been identified in
Massachusetts, New York, Rhode Island, North
Carolina, and Puerto Rico. Pulsed-field gel electro-
phoresis confirmed that the seven available isolates
were indistinguishable. The results of this prelimi-
nary investigation were published in the June 18,
2004, issue of Morbidity and Mortality Weekly Report.5
EIN and other listservs have great potential to
help identify infectious-disease outbreaks and as-
sist in case identification. Although serendipity and
the presence of an uncommon pathogen obviously
contributed to the identification of this internation-
al outbreak, the use of the EIN listserv was the
proximate cause of the discovery of the outbreak.
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